NAVIGATOR data show half of patients with severe, uncontrolled asthma improved with tezepelumab therapy - EurekAlert

A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference. The study showed that nearly half of those enrolle…

Session: B93, Breakthroughs in Pediatric and Adult Asthma Clinical TrialsDate and Time:  Location:  Room 3006/3008 (West Building, Level 3), Moscone Center ATS 2022, San Francisco, CA – A greater pr… [+4162 chars]

full article...